Iruma, Japan

Takashi Ono

This inventor holds 4 USPTO granted patents. Top assignees: Mitsubishi Pharma Corporation, Yamasa Corporation, Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1997-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Ono. Retrieved from https://idiyas.com/inventor/takashi-ono-4etnc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1997-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Takashi Ono in Pharmaceutical Development**

Introduction

Takashi Ono is a notable inventor based in Iruma, Japan, with a remarkable portfolio of four patents. His innovative contributions predominantly lie in the field of pharmaceuticals, particularly focusing on Rho kinase inhibitors, which have significant therapeutic potential.

Latest Patents

Ono's latest patents include the development of a pharmaceutical agent containing Rho kinase inhibitors. This groundbreaking invention provides various therapeutic applications, such as treating hypertension, angina pectoris, and cerebrovascular contractions. Additionally, it serves as a therapeutic agent for asthma, peripheral circulation disorders, and even conditions like arteriosclerosis and cancer. The Rho kinase inhibitor also presents possibilities for being an immunosuppressant and aids in managing autoimmune diseases, as well as offering contraceptive and diagnostic applications. The versatility of this agent shows promise for improving brain function and addressing numerous health challenges.

Career Highlights

Throughout his career, Takashi Ono has worked with prominent organizations, including Mitsubishi Pharma Corporation and Yoshitomi Pharmaceutical Industries, Ltd. These experiences have enabled him to contribute significantly to the advancement of medicinal therapeutics, particularly in the domain of Rho kinase inhibitors.

Collaborations

Ono's journey in innovation has also involved collaboration with esteemed individuals such as Masayoshi Uehata and Hiroyuki Satoh. These partnerships have been instrumental in enhancing the research and development of his patented inventions.

Conclusion

In conclusion, Takashi Ono stands out as a prominent inventor whose work with Rho kinase inhibitors reflects his commitment to advancing pharmaceutical science. His innovative approach to addressing various health conditions through targeted therapies showcases the vital role inventors play in improving global health outcomes. As he continues to develop and refine his inventions, the impact of his work is likely to reverberate through the healthcare industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…